THERAGENICS CORP
10-Q, EX-27, 2000-11-07
PHARMACEUTICAL PREPARATIONS
Previous: THERAGENICS CORP, 10-Q, 2000-11-07
Next: MORLEX INC /CO, PRE 14A, 2000-11-07



<TABLE> <S> <C>

<ARTICLE> 5
<MULTIPLIER> 1,000
<CURRENCY> U.S. DOLLARS

<S>                             <C>
<PERIOD-TYPE>                   9-MOS
<FISCAL-YEAR-END>                          DEC-31-2000
<PERIOD-START>                             JAN-01-2000
<PERIOD-END>                               SEP-30-2000
<EXCHANGE-RATE>                                      1
<CASH>                                          23,321
<SECURITIES>                                    19,991
<RECEIVABLES>                                    6,431
<ALLOWANCES>                                         0
<INVENTORY>                                      1,246
<CURRENT-ASSETS>                                52,307
<PP&E>                                          72,790
<DEPRECIATION>                                  14,533
<TOTAL-ASSETS>                                 125,309
<CURRENT-LIABILITIES>                            3,998
<BONDS>                                              0
                                0
                                          0
<COMMON>                                           295
<OTHER-SE>                                           0
<TOTAL-LIABILITY-AND-EQUITY>                   125,309
<SALES>                                         33,264
<TOTAL-REVENUES>                                33,339
<CGS>                                           10,356
<TOTAL-COSTS>                                   17,013
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                 109
<INCOME-PRETAX>                                 23,064
<INCOME-TAX>                                     8,160
<INCOME-CONTINUING>                             14,904
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                    14,904
<EPS-BASIC>                                        .50
<EPS-DILUTED>                                      .50


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission